Meyer R. Heyman

3.8k citations
22 papers · 2.8k · 1 hit paper · h-index 14

Impact in

Papers in

    • Multiple Myeloma Research and Treatments 5
    • Acute Myeloid Leukemia Research 3
    • Blood groups and transfusion 2
    • Retinoids in leukemia and cellular processes 2
    • Biochemical and Molecular Research 2

Meyer R. Heyman

21 papers receiving 2.7k citations

Meyer R. Heyman's Hit Papers

Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program. 1998 · 2.2k citations
2.2k0+9+18Years since publication50010001.5k2.0k

Peers

Meyer R. Heyman
Comparison fields: 5 of 87
  • Genetics 924
  • Pathology and Forensic Medicine 1.4k
  • Oncology 1.1k
  • Hematology 436
  • Immunology 699
Replace C. Varns with:
C. Varns United States
Diying Shen China
Isabelle Bence‐Bruckler Canada
Tak Takvorian United States
Joke W. Baars Netherlands
Barry I. Samuels United States
Amanda F. Cashen United States
Mathias Witzens‐Harig Germany
H Tilly France
Christian H. Geisler Denmark
Meyer R. Heyman relative to C. Varns United States C. Varns's profile →
Citations per field
00.5×2.5×
C. Varns · 1×
Citations per year

Countries citing papers authored by Meyer R. Heyman

Since Specialization
Citations

This map shows the geographic impact of Meyer R. Heyman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meyer R. Heyman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meyer R. Heyman more than expected).

Fields of papers citing papers by Meyer R. Heyman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meyer R. Heyman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meyer R. Heyman. The network helps show where Meyer R. Heyman may publish in the future.

Co-authors

The 25 scholars most cited alongside Meyer R. Heyman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Meyer R. Heyman Line = papers co-authored together Meyer R. Heyman links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four-dose treatment program.
Hit paper breakdown →
19982153
2 2007175
3 1996116
4 200576
5
Platelet transfusion therapy for the cancer patient.
199041
6 200436
7 200227
8 198727
9 200624
10 199324
11 198819
12 200116
13 198815
14 200813
15 198713
16 199512
17 199010
18 19879
19 19918
20 20056

About Meyer R. Heyman

Meyer R. Heyman is a scholar working on Hematology, Molecular Biology, Genetics, Pathology and Forensic Medicine and Oncology, having authored 22 papers that have together received 2.8k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (5 papers), Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Acute Myeloid Leukemia Research (3 papers), Blood disorders and treatments (3 papers), Retinoids in leukemia and cellular processes (2 papers), Blood groups and transfusion (2 papers) and Biochemical and Molecular Research (2 papers). The work is most often cited by research in Genetics (924 citations), Pathology and Forensic Medicine (1.4k citations), Oncology (1.1k citations), Hematology (436 citations) and Immunology (699 citations). Meyer R. Heyman has collaborated with scholars based in United States, Spain and Canada. Frequent co-authors include Brian K. Link, B.K. Dallaire, Isabelle Bence‐Bruckler, Christine A. White, M. S. Czuczman, Ronald Levy, Diying Shen, Peter McLaughlin, John Lister and Anthony D. Ho. Their work appears in journals such as Journal of Clinical Oncology, American Journal of Hematology, Cancer, American Journal of Clinical Pathology and Clinical Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact